GlaxoSmithKline Pharmaceuticals Limited — Important, 27-06-2025: General Updates

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting on the financial results for the quarter and half-year. At the 100th Annual General Meeting, key resolutions were approved, including adoption of audited financial statements, declaration of a final dividend of Rs 42 per share, re-appointment of Mr. Juby Chandy as Director, re-appointment of Dr. Sunita Maheshwari as Independent Director, appointment of Parikh & Associates as Secretarial Auditors, and ratification of remuneration to the Cost Auditors. All resolutions passed with overwhelming shareholder approval. No operational or business changes were reported.